Compounds > caffeine

caffeine and alvocidib

caffeine has been researched along with alvocidib in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Johnson, LN; Oikonomakos, NG; Schnier, JB; Skamnaki, VT; Tsitsanou, KE; Zographos, SE1
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Krimm, I; Lancelin, JM; Praly, JP1
Bradbury, EM; Gorin, FA; Kaiser, A; Nishi, K; Schnier, JB; Walsh, DA1
Bischler, N; Chrysina, ED; Eisenbrand, G; Kosmopoulou, MN; Leonidas, DD; Oikonomakos, NG; Pauptit, R; Sakarellos, CE1

Other Studies

6 other study(ies) available for caffeine and alvocidib

ArticleYear
Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site.
    The Journal of biological chemistry, 2000, Nov-03, Volume: 275, Issue:44

    Topics: Animals; Binding Sites; Caffeine; Flavonoids; Glucose; Kinetics; Models, Molecular; Muscle, Skeletal; Phosphorylases; Piperidines; Protein Conformation; Rabbits

2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Binding evaluation of fragment-based scaffolds for probing allosteric enzymes.
    Journal of medicinal chemistry, 2012, Feb-09, Volume: 55, Issue:3

    Topics: Allosteric Regulation; Binding Sites; Enzyme Inhibitors; Glycogen Phosphorylase; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Protein Binding; Structure-Activity Relationship

2012
The cyclin-dependent kinase (CDK) inhibitor flavopiridol inhibits glycogen phosphorylase.
    Archives of biochemistry and biophysics, 2001, Feb-15, Volume: 386, Issue:2

    Topics: Adenosine Monophosphate; Amino Acid Sequence; Animals; Brain; Caffeine; Calmodulin-Binding Proteins; Cyclin-Dependent Kinases; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Glycogen; HeLa Cells; Humans; Isoenzymes; Liver; Molecular Sequence Data; Muscle, Skeletal; Nerve Tissue Proteins; Neurogranin; Peptide Fragments; Phosphorylases; Phosphorylation; Piperidines; Protein Binding; Rabbits; Tumor Cells, Cultured

2001
Binding of the potential antitumour agent indirubin-5-sulphonate at the inhibitor site of rabbit muscle glycogen phosphorylase b. Comparison with ligand binding to pCDK2-cyclin A complex.
    European journal of biochemistry, 2004, Volume: 271, Issue:11

    Topics: Animals; Antineoplastic Agents; Binding Sites; Caffeine; CDC2-CDC28 Kinases; Cyclin A; Cyclin-Dependent Kinase 2; Enzyme Inhibitors; Flavonoids; Glucose; Glycogen Phosphorylase, Muscle Form; Indoles; Ligands; Macromolecular Substances; Models, Molecular; Muscles; Piperidines; Rabbits; Sulfonic Acids

2004